Fig. 5 

HBOT recovers rapamycin-induced mTOR pathway inhibition. A Western blot for phosphorylated S6K1 (S6K1-P) and β-actine in each experimental group (triplicate). The first row shows DMSO control group. The second row shows the rapamycin control group. The third row shows the rapamycin and HBOT groups. The last row shows the DMSO and HBOT groups. HBOT sessions for 20 days. B Quantification of pixel intensity for S6K1-P presence in each group normalized to internal control β-actine. Asterisks indicate statistical significance. Permutation test. < 0.05, n = 4 per group